572 results on '"Atsuta, Yoshiko"'
Search Results
2. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors
3. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy
4. Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation
5. Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation
6. Impact of Early Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation on Relapse in Patients with Myelodysplastic Syndrome: A Nationwide Retrospective Study from Adult Myelodysplastic Syndrome Working Group of the JSTCT
7. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
8. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT
9. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time periods in Japan
10. RhD mismatch does not affect haematopoietic recovery, graft‐versus‐host disease and survival in allogeneic haematopoietic cell transplantation: A Japanese registry‐based study
11. International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update
12. Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis
13. Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
14. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study
15. The effect of center experience on allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia
16. American Society for Transplantation and Cellular Therapy International Affairs Committee: Report of the 4th Workshop on Quality as a Development Tool for Hematopoietic Cell Transplantation Programs at the 2023 Tandem BMT Meetings
17. Development of the Umbilical Cord Blood Transplantation-Specific Non-Relapse Mortality Risk Assessment Score: A Study from the Donor/Source and Transplant Complication Working Groups of Jstct
18. Comparison of Melphalan Dose in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Transplantation with Reduced-Intensity Conditioning
19. Validation and Refinement of Day 28 Overall Response after Treatment for Acute Graft-Versus-Host Disease
20. Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
21. Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy
22. A Nationwide Retrospective Analysis of Allogeneic Hematopoietic Stem Cell Transplantation for Adult Hemophagocytic Lymphohistiocytosis
23. Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: A nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy
24. Allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia not in remission
25. Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study
26. Effect of conditioning regimens and GVHD prophylaxis on the outcomes of umbilical cord blood transplantation performed with cyclophosphamide/total-body irradiation-based regimens
27. Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia
28. Comparison of allogeneic transplant outcomes between matched sibling donors and alternative donors in patients over 50 years of age with acute myeloid leukemia: 8/8 allele-matched unrelated donors and unrelated cord blood provide better leukemia-free survival compared with matched sibling donors during non-remission status
29. Scoring system for optimal cord blood unit selection for single cord blood transplantation
30. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia
31. Hematopoietic stem cell transplantation from haploidentical offspring donors using post‐transplant cyclophosphamide versus human leukocyte antigen‐matched siblings in older patients with myelodysplastic syndrome
32. Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
33. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey
34. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma
35. Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients
36. Effect of graft-versus-host disease on outcomes of HLA-haploidentical peripheral blood transplantation using post-transplant cyclophophamide
37. The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation
38. HLA-haploidentical Peripheral Blood Stem Cell Transplantation with Post-transplant Cyclophosphamide versus HLA-matched Unrelated Donor Transplantation for Myelodysplastic Syndrome
39. Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect
40. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades
41. Single‐unit unrelated cord blood transplantation versus HLA‐matched sibling transplantation in adults with advanced myelodysplastic syndrome: A registry‐based study from the adult MDS working group of the Japanese society for transplantation and cellular therapy
42. Impact of HLA disparity on overall mortality risk in patients with extensive chronic GVHD: The HLA Working Group of Japanese Society for Transplantation and Cellular Therapy
43. P1265: UNRELATED FEMALE-TO-MALE BONE MARROW TRANSPLANTATION SHOULD BE PREFERRED OVER CORD BLOOD TRANSPLANTATION IN MALE RECIPIENTS.
44. P1323: THE PROGNOSIS AND COMPLICATIONS OF PATIENTS WITH PRE-TRANSPLANT LIVER DYSFUNCTION
45. Efficacy of Autologous Stem Cell Transplantation for Myeloma Patients with Suboptimal Response: A Multicenter Retrospective Analysis
46. Selection of Cord Blood Unit by CD34+ Cell and GM-CFU Numbers and Allele-Level HLA Matching in Single Cord Blood Transplantation
47. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ALL: A retrospective nationwide study
48. Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant
49. Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs
50. Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.